CORRECTION: Apyx Medical Q2 Adj $(0.11) Misses $(0.07) Estimate, Sales $13.57M Miss $14.32M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical's Q2 adjusted earnings per share of $(0.11) missed the estimated $(0.07), and sales of $13.57M also fell short of the $14.32M estimate.
August 10, 2023 | 9:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apyx Medical's Q2 results missed estimates, which could negatively impact investor sentiment and the company's stock price in the short term.
Earnings reports are a significant factor in a company's stock price. Apyx Medical's Q2 results missed estimates, which could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100